Publication:
Liver cirrhosis and sarcopenia: a dreadful combination.

Loading...
Thumbnail Image

Date

2022-09-05

Authors

Kuchay, Mohammad Shafi
Martinez-Montoro, Jose Ignacio
Llamoza-Torres, Camilo Julio
Fernandez-Garcia, Jose Carlos
Ramos-Molina, Bruno

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

AME Publishing Company
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Patients with liver cirrhosis, irrespective of etiology, have increased risk of liver-related and all-cause mortality (1). Also, the severity of cirrhosis determines health outcomes. For instance, patients with compensated cirrhosis have a nearly five-fold increased risk of death, while those with decompensated cirrhosis have approximately a 10-fold increased risk compared with the general population (1). Furthermore, the median survival time of patients with compensated cirrhosis is 12 years, while it is only 1.8 years in those with decompensated cirrhosis (2). Moreover, the presence of intercurrent conditions, such as sarcopenia (loss of skeletal muscle mass and function) may also compromise the prognosis of patients with cirrhosis (3).

Description

MeSH Terms

Humans
Prognosis
Muscle, Skeletal
Outcome Assessment, Health Care

DeCS Terms

Fibrosis
Músculo esquelético
Hígado
Pronóstico
Cirrosis hepática

CIE Terms

Keywords

Fibrosis, Sarcopenia, Death, Liver Cirrhosis, Mortality

Citation

Kuchay MS, Martínez-Montoro JI, Llamoza-Torres CJ, Fernández-García JC, Ramos-Molina B. Liver cirrhosis and sarcopenia: a dreadful combination. Hepatobiliary Surg Nutr. 2022 Oct;11(5):729-731